Avendus’s Healthcare practice leverages deep domain knowledge of pharma industry, healthcare providers and services, significant transaction and operating experience to provide strategic and corporate finance advice to a wide range of clients including growing businesses, large corporate houses and private equity funds. The group’s philosophy on every transaction revolves around senior team attention, hands-on approach and independent advice delivering best-in-class solutions to clients.
Sub-Sectors in Focus
Our mergers and acquisitions (M&A) advisory and private equity (PE) syndication services are recognized as amongst the best in these chosen sub-sectors.
- Pharmaceuticals - generics/specialty generics, specialty pharmaceuticals, API / CDMO / CRO
- Healthcare delivery - hospitals, diagnostics, single specialty
- Medical technology - lifesciences, medical devices, consumables
Led By
Anshul Gupta
Managing Director and Head, Healthcare Investment Banking, Avendus Capital
Anshul Gupta is a seasoned dealmaker with over 18 years of M&A experience. He heads the Healthcare vertical at Avendus and is based in Mumbai.
Anshul has spent the last 15 years in various leadership roles at Citigroup Global Markets. He led several noteworthy transactions during his tenure in the Healthcare and Finance sector including, IHH’s acquisition of Fortis, the sale of Siemens India’s Healthcare business to its parent, private placement in TPG-owned Pathology Asia Holdings and the sale of Citi’s consumer business to Axis. He is also an expert in capital markets, having led IPOs for Gland Pharma, Laurus Labs and Eris Lifesciences, QIPs for Max Health and Piramal, financing for Intas’ acquisition of Actavis and bond issuances for Glenmark and Jubilant Pharma, among others.
He holds an MBA degree from the University of Chicago’s Booth School of Business and an engineering degree from IIT, Delhi.
Transactions
Reports
The Resilient Reset of India’s Microfinance Sector
India’s microfinance sector is undergoing a structural reset bolstered by regulatory guardrails, stronger credit discipline, and operational recalibration. These shifts are expected to drive gross loan portfolio growth at 15%+ CAGR over the next 5-6 years. Our latest thought paper explores this opportunity and its implications for one of India’s most critical engines of financial inclusion.
Single Specialties Carving Their Own Path in Indian Healthcare
Organized single specialty hospitals are emerging as a high-growth segment within India’s healthcare landscape, projected to cross USD 9 billion by 2028. Multiple specialties are breaking away from traditional multi-specialty setups driven by low inter-disciplinary dependencies, high specificity of symptoms and infrastructure requirements, lower capex intensity, attractive unit economics and strong investor interest. Our latest report deep-dives into eight key specialties and the evolving landscape of India’s single specialty healthcare.
Energy Transition Materials Imperative to India's self-reliance in clean energy
Energy transition is driving unprecedented demand for materials like lithium, nickel, cobalt, rare earths and graphite. With over 60% of processing capacity concentrated in China, supply chain risks associated with these materials are significantly higher. India’s heavy reliance on imports of these materials also makes energy security a challenge. Our latest report explores ETM risks, supply-demand trends, and opportunities for India to build a self-reliant value chain.
Transformative Transactions in Technology Services
With USD 330 Bn+ worth of transformative deals in IT Services over the past decade, the industry is evolving at a rapid speed. The industry is also witnessing a surge in billion-dollar deals across niche sectors like Digital Engineering Services (DES), Healthcare Revenue Cycle Management (RCM), and Cloud and Analytics. Driven by growing investor interest, emerging buyers, and strong sub-segment growth, our report explores key trends, high-value targets, and the dominance of PE and strategic players shaping the future of this dynamic space.
Indian Alternatives Market: Poised for USD 2 Trillion by 2034
India’s Alternatives market, currently valued at USD 400 billion, is set for exponential growth, driven by increasing HNI wealth, a favourable regulatory environment, and rising demand for differentiated products. Our report explores the key trends, investment opportunities, and sectoral drivers, projecting the market to reach USD 2 trillion in the next decade, unlocking immense value-creation potential.
US Healthcare RCM Services: A USD 28 Billion Market Opportunity by 2029
The market for outsourced Revenue Cycle Management services has grown multi-fold in the recent years, driven by several factors such as, complexity of medical codes and workflows across the RCM value chain, shortage of talent, and growing pressure on overall profitability of providers. Our report highlights the key trends, technology adoption, and investment opportunities in this high-growth sector.